|
1
|
Lowy FD: Staphylococcus aureus
infections. N Engl J Med. 339:520–532. 1998. View Article : Google Scholar
|
|
2
|
Klevens RM, Morrison MA, Nadle J, Petit S,
Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM,
et al: Invasive methicillin-resistant Staphylococcus aureus
infections in the United States. JAMA. 298:1763–1771. 2007.
View Article : Google Scholar
|
|
3
|
Kitur K and Prince A: Staphylococcus
aureus activation of NLRP3 inflammasome and necroptosis through
MLKL exacerbates pneumonia. FASEB J. 29 1 Suppl:S148.52015.
|
|
4
|
Duewell P, Kono H, Rayner KJ, Sirois CM,
Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nuñez G, Schnurr
M, et al: NLRP3 inflammasomes are required for atherogenesis and
activated by cholesterol crystals. Nature. 464:1357–1361. 2010.
View Article : Google Scholar
|
|
5
|
Heneka MT, Kummer MP, Stutz A, Delekate A,
Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng TC, et
al: NLRP3 is activated in Alzheimer/'s disease and contributes to
pathology in APP/PS1 mice. Nature. 493:674–678. 2013. View Article : Google Scholar
|
|
6
|
Lee HM, Kim JJ, Kim HJ, Shong M, Ku BJ and
Jo EK: Upregulated NLRP3 inflammasome activation in patients with
type 2 diabetes. Diabetes. 62:194–204. 2013. View Article : Google Scholar
|
|
7
|
Jin C and Flavell RA: Molecular mechanism
of NLRP3 inflammasome activation. J Clin Immunol. 30:628–631. 2010.
View Article : Google Scholar
|
|
8
|
Kanneganti TD, Body-Malapel M, Amer A,
Park JH, Whitfield J, Franchi L, Taraporewala ZF, Miller D, Patton
JT, Inohara N and Núñez G: Critical role for Cryopyrin/Nalp3 in
activation of caspase-1 in response to viral infection and
double-stranded RNA. J Biol Chem. 281:36560–36568. 2006. View Article : Google Scholar
|
|
9
|
Muruve DA, Périlli V, Zaiss AK, White LR,
Clark SA, Ross PJ, Parks RJ and Tschopp J: The inflammasome
recognizes cytosolic microbial and host DNA and triggers an innate
immune response. Nature. 452:103–107. 2008. View Article : Google Scholar
|
|
10
|
Wilson D, Thewes S, Zakikhany K, Fradin C,
Albrecht A, Almeida R, Brunke S, Grosse K, Martin R, Mayer F, et
al: Identifying infection-associated genes of Candida
albicans in the postgenomic era. FEMS Yeast Res. 9:688–700.
2009. View Article : Google Scholar
|
|
11
|
Mariathasan S, Weiss DS, Newton K, McBride
J, O'Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM and
Dixit VM: Cryopyrin activates the inflammasome in response to
toxins and ATP. Nature. 440:228–232. 2006. View Article : Google Scholar
|
|
12
|
Willingham SB, Bergstralh DT, O'Connor W,
Morrison AC, Taxman DJ, Duncan JA, Barnoy S, Venkatesan MM, Flavell
RA, Deshmukh M, et al: Microbial pathogen-induced necrotic cell
death mediated by the inflammasome components CIAS1/cryopyrin/NLRP3
and ASC. Cell Host Microbe. 2:147–159. 2007. View Article : Google Scholar
|
|
13
|
Craven RR, Gao X, Allen IC, Gris D,
Wardenburg Bubeck J, McElvania-TeKippe E, Ting JP and Duncan JA:
Staphylococcus aureus alpha-hemolysin activates the
NLRP3-inflammasome in human and mouse monocytic cells. PLoS One.
4:e74462009. View Article : Google Scholar
|
|
14
|
Kebaier C, Chamberland RR, Allen IC, Gao
X, Broglie PM, Hall JD, Jania C, Doerschuk CM, Tilley SL and Duncan
JA: Staphylococcus aureus α-hemolysin mediates virulence in
a murine model of severe pneumonia through activation of the NLRP3
inflammasome. J Infect Dis. 205:807–817. 2012. View Article : Google Scholar
|
|
15
|
Chun-Fu W, Jing-Yu Y, Fang W and Xiao-Xiao
W: Resveratrol: Botanical origin, pharmacological activity and
applications. Chin J Nat Med. 11:1–15. 2013.
|
|
16
|
Bollmann F, Art J, Henke J, Schrick K,
Besche V, Bros M, Li H, Siuda D, Handler N, Bauer F, et al:
Resveratrol post-transcriptionally regulates pro-inflammatory gene
expression via regulation of KSRP RNA binding activity. Nucleic
Acids Res. 42:12555–12569. 2014. View Article : Google Scholar
|
|
17
|
Hwang D and Lim YH: Resveratrol
antibacterial activity against Escherichia coli is mediated by
Z-ring formation inhibition via suppression of FtsZ expression. Sci
Rep. 5:100292015. View Article : Google Scholar
|
|
18
|
Gülçin İ: Antioxidant properties of
resveratrol: A structure-activity insight. Innov Food Sci Emerg
Technol. 11:210–218. 2010. View Article : Google Scholar
|
|
19
|
Marino A, Santoro G, Spataro F, Lauriano
ER, Pergolizzi S, Cimino F, Speciale A, Nostro A, Bisignano G and
Dugo G: Resveratrol role in Staphylococcus aureus-induced
corneal inflammation. Pathog Dis. 68:61–64. 2013. View Article : Google Scholar
|
|
20
|
Lee IT, Lin CC, Hsu CK, Wu MY, Cho RL and
Yang CM: Resveratrol inhibits Staphylococcus aureus-induced
TLR2/MyD88/NF-κB-dependent VCAM-1 expression in human lung
epithelial cells. Clin Sci (Lond). 127:375–390. 2014. View Article : Google Scholar
|
|
21
|
Dong W, Yang R, Yang J, Yang J, Ding J, Wu
H and Zhang J: Resveratrol pretreatment protects rat hearts from
ischemia/reperfusion injury partly via a NALP3 inflammasome
pathway. Int J Clin Exp Patho. 8:8731–8741. 2015.
|
|
22
|
Yang SJ and Lim Y: Resveratrol ameliorates
hepatic metaflammation and inhibits NLRP3 inflammasome activation.
Metabolism. 63:693–701. 2014. View Article : Google Scholar
|
|
23
|
Chang YP, Ka SM, Hsu WH, Chen A, Chao LK,
Lin CC, Hsieh CC, Chen MC, Chiu HW, Ho CL, et al: Resveratrol
inhibits NLRP3 inflammasome activation by preserving mitochondrial
integrity and augmenting autophagy. J Cell Physiol. 230:1567–1579.
2015. View Article : Google Scholar
|
|
24
|
Veterinary Anesthetic and Analgesic
Formulary. 3rd edition. Version G. University of Colorado Denver,
Anschutz Medical Campus; 2012
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
26
|
Zhang Y, Wang JF, Dong J, Wei JY, Wang YN,
Dai XH, Wang X, Luo MJ, Tan W, Deng XM and Niu XD: Inhibition of
α-toxin production by subinhibitory concentrations of naringenin
controls Staphylococcus aureus pneumonia. Fitoterapia.
86:92–99. 2013. View Article : Google Scholar
|
|
27
|
Qiu J, Niu X, Dong J, Wang D, Wang J, Li
H, Luo M, Li S, Feng H and Deng X: Baicalin protects mice from
Staphylococcus aureus pneumonia via inhibition of the
cytolytic activity of α-hemolysin. J Infect Dis. 206:292–301. 2012.
View Article : Google Scholar
|
|
28
|
Dong J, Qiu J, Wang J, Li H, Dai X, Zhang
Y, Wang X, Tan W, Niu X, Deng X and Zhao S: Apigenin alleviates the
symptoms of Staphylococcus aureus pneumonia by inhibiting
the production of alpha-hemolysin. FEMS Microbiol Lett.
338:124–131. 2013. View Article : Google Scholar
|
|
29
|
Su Y, Ma L, Wen Y, Wang H and Zhang S:
Studies of the in vitro antibacterial activities of several
polyphenols against clinical isolates of methicillin-resistant
Staphylococcus aureus. Molecules. 19:12630–12639. 2014.
View Article : Google Scholar
|
|
30
|
Zhao G, Wu H, Jiang K, Rui G, Zhu Z, Qiu
C, Guo M and Deng G: IFN-τ inhibits S. aureus-induced inflammation
by suppressing the activation of NF-κB and MAPKs in RAW 264.7 cells
and mice with pneumonia. Int Immunopharmacol. 35:332–340. 2016.
View Article : Google Scholar
|
|
31
|
Muñoz-Planillo R, Franchi L, Miller LS and
Núñez G: A critical role for hemolysins and bacterial lipoproteins
in Staphylococcus aureus-induced activation of the Nlrp3
inflammasome. J Immunol. 183:3942–3948. 2009. View Article : Google Scholar
|
|
32
|
Netea MG, Nold-Petry CA, Nold MF, Joosten
LA, Opitz B, van der Meer JH, van de Veerdonk FL, Ferwerda G,
Heinhuis B, Devesa I, et al: Differential requirement for the
activation of the inflammasome for processing and release of
IL-1beta in monocytes and macrophages. Blood. 113:2324–2335. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Strowig T, Henao-Mejia J, Elinav E and
Flavell R: Inflammasomes in health and disease. Nature.
481:278–286. 2012. View Article : Google Scholar : PubMed/NCBI
|
